Expert insights. Personalized for you.
Sales Related Topics 
Bio Pharma Dive
NOVEMBER 3, 2022
The biotech dialed back its financial projections after reporting lower-than-expected sales for the shot, which currently remains the company’s only marketed product
Bio Pharma Dive
JULY 27, 2022
A manufacturing issue for Breyanzi, meanwhile, impacted sales Demand has increased faster than Bristol Myers can make Abecma, although the company said supply is improving.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
NOVEMBER 9, 2022
While many companies are still unsure of the Inflation Reduction Act's effects, some have begun to warn investors about the likelihood of lower sales and reduced profitability
Bio Pharma Dive
AUGUST 23, 2022
The biotech successfully brought two medicines to market, but shares have lost most of their value amid sluggish sales
Speaker: Steve Goldstein, Sales Leader
Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.
Bio Pharma Dive
NOVEMBER 2, 2022
Manufacturing problems continue to weigh on Novo’s Wegovy launch as competition looms from Eli Lilly’s fast-selling diabetes medicine Mounjaro
Bio Pharma Dive
OCTOBER 25, 2022
Treatment is now mostly of infants newly diagnosed with spinal muscular atrophy, as many of those previously eligible either already received Zolgensma or other drugs from Biogen and Roche
Bio Pharma Dive
AUGUST 17, 2022
The federal government will begin the transition as early as this fall, clearing the way for drugmakers to control sales and distribution of their shots and therapeutics
Bio Pharma Dive
JULY 21, 2021
billion in sales from its shot this year, despite concerns over protection against variants and significant manufacturing setbacks The pharmaceutical company expects $2.5
Pharma Phorum
OCTOBER 13, 2021
Create and disseminate sales support materials. Manage and develop sales team (sales manager role only). Proven experience of working as part of a sales team. Proven work experience working in a sales-based role. The post Sales manager appeared first on.
Bio Pharma Dive
FEBRUARY 5, 2021
Sales of the antiviral drug accounted for a quarter of the biotech's product revenue in the fourth quarter, disguising hits to its business elsewhere
Bio Pharma Dive
JULY 29, 2022
Imbruvica, long one of AbbVie’s top-selling medicines, has ceded market share in treating chronic lymphocytic leukemia to AstraZeneca’s Calquence
Bio Pharma Dive
DECEMBER 22, 2021
Leqvio, which Novartis acquired for nearly $10 billion two years ago, arrives with high sales expectations. But uptake could be slow as insurers and doctors weigh the drug's safety and cost-effectiveness
Bio Pharma Dive
OCTOBER 28, 2022
After a slow start, Gilead’s CAR-T business is growing fast, enabling it to pull ahead of rival cell therapy developers like Bristol Myers Squibb and Johnson & Johnson
Bio Pharma Dive
MAY 4, 2022
The trajectory of COVID-19 vaccine sales is now harder to predict amid questions about the rollout of additional doses and whether purchasing in the U.S.
Pharma Phorum
NOVEMBER 16, 2022
Novartis has already spun out its eyecare business Alcon, and is now considering the sale of its ophthalmology and respiratory medicines businesses as it continues a narrowing of its focus, according to media reports.
Bio Pharma Dive
FEBRUARY 17, 2022
The layoffs — which, according to Yumanity, should be completed by April — are part of a larger restructuring effort meant to reduce costs after a recent setback to the company's most advanced drug program
Bio Pharma Dive
APRIL 29, 2021
Both companies blamed the impact of COVID-19 on sharp declines in sales of their shingles, pneumonia and HPV shots
Bio Pharma Dive
NOVEMBER 1, 2022
Company executives highlighted the “viral nature” of demand for Mounjaro, which was approved in May for diabetes and has also shown a strong weight-loss benefit in clinical testing
Bio Pharma Dive
OCTOBER 18, 2021
The company hopes a "streamlined" sales force can turn around a drug launch that's failed to meet expectations amid tough competition from rival medicines
Bio Pharma Dive
OCTOBER 28, 2021
But sales could climb even higher if it works as a preventive treatment too Executives based their projections on contracts already in place for the drug, known as molnupiravir.
Bio Pharma Dive
FEBRUARY 3, 2022
Aduhelm sales totaled just $1 million in the fourth quarter as Biogen struggles to win over doctors and insurers. The company said it would reduce expenses by more than currently planned if Medicare limits coverage
Bio Pharma Dive
APRIL 28, 2022
Sio Gene Therapies, formerly known as Axovant, said it's focused on conserving cash, and has decided to significantly reduce its workforce and terminate licensing agreements on its last two pipeline programs
Bio Pharma Dive
FEBRUARY 2, 2021
The estimate for 2021 sales, which Pfizer splits with partner BioNTech, would make the vaccine one of the highest-selling medicines in the industry
Bio Pharma Dive
FEBRUARY 10, 2022
The biotech is predicting sales of Tukysa, its new breast cancer drug, will remain flat or fall in 2022 as competition increases from AstraZeneca's rival medicine Enhertu
Bio Pharma Dive
FEBRUARY 8, 2022
The company estimated revenue from its COVID-19 vaccine and antiviral pill Paxlovid will total $54 billion this year. Curiously, its stock fell by more than 5
BioSpace
OCTOBER 5, 2022
Find out what it takes to become a successful pharma sales rep and discover helpful career advancement tips for pharmaceutical sales professionals
Bio Pharma Dive
JULY 31, 2020
Pfizer, Sanofi, GSK and Merck each reported lower vaccine sales as stay-at-home orders kept people from their regular vaccinations
Bio Pharma Dive
NOVEMBER 2, 2021
The drugmaker again increased its forecast for 2021 sales, this time to $36 billion, or about 80% of what the rest of Pfizer's business is expected to earn this year
Bio Pharma Dive
MAY 5, 2022
The biotech reported positive results from a study meant to expand Vyvgart's use to another immune disorder, while sales from the drug's first quarter on the market exceeded expectations
XTalks
NOVEMBER 29, 2022
Despite higher input costs and supply chain struggles, the company saw quarterly sales growth fueled by the market strength of its beloved crustless peanut butter and jelly sandwiches. Total company net sales of Uncrustables sandwiches were $168 million this quarter.”.
Pharmaceutical Commerce
AUGUST 11, 2022
Contract sales organizations are evolving alongside the companies they serve.
Bio Pharma Dive
JULY 8, 2021
Second quarter sales of Nurtec ODT, which recently became the first migraine drug cleared for acute and preventive treatment, were nearly twice what analysts on Wall Street had predicted
Bio Pharma Dive
JULY 28, 2022
The company plans to ready a booster shot by the fall that targets the BA.4 and BA.5 strains that are currently most prevalent in the U.S. and other countries
Bio Pharma Dive
JULY 12, 2022
A former Celgene executive, Jackie Fouse has led Agios since 2019, overseeing its transformation into a company focused solely on uncommon diseases. In August, she will transition to chair its board of directors
Pharma Phorum
JUNE 6, 2022
Eversana’s suite of commercialisation tools for pharma companies will soon have a new component – cognitive behavioural training tools designed to improve the performance of sales representatives. Digital News Sales and Marketing digital Sales reps Training
Bio Pharma Dive
AUGUST 3, 2022
Together, the biotech’s two CAR-T therapies earned $368 million between April and June, a substantial jump over last year and above what analysts forecast
Bio Pharma Dive
FEBRUARY 9, 2022
Facing falling sales of top-seller Enbrel, the biotech tried to shore up confidence in its ability to grow new products, like the cancer drug Lumakras
Pharma Phorum
NOVEMBER 9, 2021
COVID-19 has been a catalyst for a huge amount of change across the pharmaceutical industry, acting as an accelerant for progress in its use of digital technology and prompting a reassessment of how the sales function should work. The industry faces the dawn of a new age in sales coaching.
Pharma Phorum
OCTOBER 6, 2022
Servier is already in the process of transforming itself into a much bigger player in cancer, and has just tripled its sales objectives for the category. ” Its updated plan predicts group sales of €6 billion in 2025 and operating profits of around €1.3
Pharma Mirror
OCTOBER 17, 2022
The post Artificial Intelligence (AI) in Pharma Sales and Marketing appeared first on Pharma Mirror Magazine. Pharmaceutical Articles artificial intelligence Pharma Sales and MarketingWhat is AI?
Bio Pharma Dive
FEBRUARY 17, 2021
The Swiss drugmaker's pill Entresto is now cleared in the U.S. for use in patients with stronger hearts, expanding the eligible population by two-thirds
Bio Pharma Dive
MARCH 15, 2022
Instead of sharing global profits and losses, Eisai will receive royalties tied to net sales of the Alzheimer's drug. Biogen, meanwhile, said the amended deal should make it easier to "address market developments "
246 
Let's personalize your content